Omnacortil: Potent Glucocorticoid for Effective Inflammation Control
Similar products
Omnacortil is a pharmaceutical preparation containing the active ingredient Prednisolone, a synthetic glucocorticoid renowned for its potent anti-inflammatory and immunosuppressive properties. It is a cornerstone in the management of a wide spectrum of inflammatory, allergic, and autoimmune disorders. This corticosteroid works by modulating the body’s immune response, effectively reducing inflammation and suppressing abnormal immune activity. Available in various strengths, including the commonly prescribed 5mg and 20mg tablets, Omnacortil provides clinicians with a versatile tool for both short-term intervention and long-term disease management protocols. Its efficacy is well-established through decades of clinical use across numerous medical specialties.
Features
- Active ingredient: Prednisolone
- Available in tablet formulations (e.g., 5mg, 10mg, 20mg, 40mg)
- Rapid oral absorption with high bioavailability
- Demonstrated potent glucocorticoid and mild mineralocorticoid activity
- Multiple international manufacturers ensure consistent supply and quality
- Standardized dosing allows for precise titration
Benefits
- Provides rapid and potent suppression of inflammatory pathways, leading to swift symptomatic relief in acute flare-ups.
- Effectively modulates the immune system, making it invaluable for managing autoimmune conditions where the body attacks its own tissues.
- Helps prevent long-term tissue damage and organ dysfunction caused by uncontrolled chronic inflammation.
- Offers flexible dosing regimens that can be tailored to the severity of the condition and individual patient response.
- Can be used as a monotherapy or as part of a combination treatment strategy with other immunosuppressive agents.
- A well-understood pharmacological profile with extensive clinical history, providing a high degree of predictability for healthcare providers.
Common use
Omnacortil (Prednisolone) is indicated for a broad range of conditions where suppression of inflammation or modulation of the immune response is therapeutically desirable. Its use spans nearly all medical disciplines.
In Rheumatology, it is a first-line treatment for systemic inflammatory conditions such as rheumatoid arthritis, polymyalgia rheumatica, and systemic lupus erythematosus (SLE). It is crucial for controlling disease activity and preventing joint erosion and systemic complications.
In Pulmonology and Allergology, it is employed for severe, acute exacerbations of asthma that are unresponsive to bronchodilators, as well as for managing chronic obstructive pulmonary disease (COPD) exacerbations. It is also used in the treatment of allergic conditions like severe contact dermatitis, angioedema, and serum sickness.
Within Gastroenterology, Omnacortil is a mainstay for inducing remission in inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis. It helps reduce intestinal inflammation, abdominal pain, and diarrhea.
In Dermatology, it treats severe skin disorders such as pemphigus vulgaris, severe psoriasis, and exfoliative dermatitis. In Hematology and Oncology, it is a key component of chemotherapeutic regimens for lymphomas and leukemias (e.g., acute lymphoblastic leukemia) due to its lympholytic effects. It is also used to manage complications like hypercalcemia of malignancy.
Furthermore, it is used for replacement therapy in adrenal insufficiency (Addison’s disease) and for suppressing graft-versus-host disease following organ transplantation.
Dosage and direction
Administration: Omnacortil tablets are for oral administration. They should be taken with food or milk to minimize potential gastrointestinal irritation.
Dosage Regimens: Dosage is highly individualized and must be strictly determined by a physician based on the specific disease, its severity, and the patient’s response. There is no universal dosage.
- Anti-inflammatory/Immunosuppressive: For most conditions, the initial dosage can range from 5 mg to 60 mg per day, often given as a single daily dose in the morning to coincide with the body’s natural cortisol rhythm.
- Physiologic Replacement: For adrenal insufficiency, the dosage is typically much lower, around 4 to 5 mg per day.
- High-Dose Therapy: For severe, life-threatening conditions (e.g., organ transplant rejection), doses can exceed 100 mg per day.
- Tapering: It is critically important that therapy not be stopped abruptly after more than a few weeks of use. The dosage must be gradually reduced (tapered) to allow the adrenal glands to resume natural cortisol production and to avoid withdrawal symptoms. The tapering schedule is patient-specific and can last from days to many months.
The prescribing physician will provide the exact dosage and duration. Never self-adjust the dose.
Precautions
- Adrenal Suppression: Prolonged use suppresses the body’s natural production of cortisol. Patients must be aware that they cannot stop the medication suddenly. Stress (e.g., surgery, trauma, severe infection) during therapy or shortly after stopping may require temporary dosage increases or reintroduction of the drug.
- Infections: Prednisolone can mask signs of infection and reduce the body’s ability to fight them. Patients should be vigilant for any signs of infection (fever, sore throat) and report them immediately. Latent infections like tuberculosis may be reactivated.
- Vaccinations: Live vaccines (e.g., MMR, yellow fever) are generally contraindicated during therapy due to the risk of uncontrolled viral replication. Inactivated vaccines may have a diminished immune response.
- Monitoring: Long-term use requires regular monitoring of blood pressure, blood glucose levels, electrolytes, bone mineral density (for osteoporosis), and eye examinations for cataracts and glaucoma.
- Special Populations: Use with extreme caution in patients with diabetes, hypertension, heart failure, osteoporosis, peptic ulcer disease, psychiatric history, or seizure disorders.
Contraindications
Omnacortil is contraindicated in patients with:
- Known hypersensitivity to Prednisolone or any excipients in the formulation.
- Systemic fungal infections (unless being used for the management of drug reactions in conjunction with specific antifungal therapy).
- Live virus vaccination in an immunocompromised patient.
- Important Note: There are no absolute contraindications in life-threatening situations. In such cases, the benefits of therapy may outweigh the risks.
Possible side effect
The incidence and severity of side effects are related to the dose and duration of therapy.
- Common: Fluid retention and edema, weight gain, increased appetite, mood swings, insomnia, indigestion, facial rounding (moon face), acne.
- Serious (require medical attention):
- Endocrine: Hyperglycemia (may precipitate steroid-induced diabetes), Cushing’s syndrome, hypothalamic-pituitary-adrenal (HPA) axis suppression.
- Cardiovascular: Hypertension, congestive heart failure.
- Musculoskeletal: Osteoporosis, vertebral compression fractures, avascular necrosis of the hip, muscle weakness (myopathy).
- Ophthalmic: Glaucoma, cataracts.
- Gastrointestinal: Peptic ulceration with potential for perforation and hemorrhage, pancreatitis.
- Dermatologic: Impaired wound healing, thin fragile skin, bruising.
- Neurologic/Psychiatric: Increased intracranial pressure, vertigo, severe depression, euphoria, psychosis.
- Immunologic: Increased susceptibility to infections.
Drug interaction
Omnacortil interacts with a wide range of medications. Inform your doctor of all drugs you are taking.
- Anticoagulants (e.g., Warfarin): Prednisolone may alter the response, requiring more frequent INR monitoring.
- Antidiabetic agents (Insulin, Oral Hypoglycemics): May antagonize their effect, increasing blood sugar and requiring dosage adjustments.
- Diuretics (e.g., Furosemide, Hydrochlorothiazide): Increases the risk of severe hypokalemia (low potassium).
- NSAIDs (e.g., Ibuprofen, Naproxen): Significantly increases the risk of gastrointestinal ulceration and bleeding.
- Enzyme Inducers (e.g., Phenytoin, Rifampicin): May increase the metabolism of Prednisolone, reducing its efficacy.
- Enzyme Inhibitors (e.g., Ketoconazole): May decrease the metabolism of Prednisolone, increasing the risk of toxicity.
- Live Vaccines: Concomitant use is contraindicated.
- Cardiac Glycosides (e.g., Digoxin): Hypokalemia increases the risk of digitalis toxicity.
Missed dose
- If you miss a dose, take it as soon as you remember.
- However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule.
- Do not double the dose to make up for a missed one.
- If you are unsure, contact your doctor or pharmacist for advice.
Overdose
An acute single overdose is unlikely to be life-threatening. However, chronic overdose leads to the development of serious side effects as described above (Cushing’s syndrome, severe hyperglycemia, etc.).
- Symptoms of acute overdose: May include fluid retention, hypertension, hyperglycemia, and psychiatric effects.
- Action: There is no specific antidote. Treatment is supportive and symptomatic. Management includes gastric lavage or activated charcoal if ingestion was recent. Electrolytes and vital signs should be monitored. Seek immediate medical attention or contact a poison control center.
Storage
- Store at room temperature (15°C - 25°C or 59°F - 77°F).
- Protect from light and moisture.
- Keep in the original container, tightly closed.
- Keep out of reach of children and pets.
- Do not use after the expiration date printed on the packaging.
- Do not flush medications down the toilet or pour them into a drain unless instructed to do so.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting or stopping any medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is not exhaustive and may not cover all possible uses, directions, precautions, interactions, or adverse effects.
Reviews
- “As a rheumatologist with over 20 years of practice, Omnacortil (Prednisolone) remains an indispensable tool. Its rapid onset of action is unparalleled for controlling acute inflammatory flares in conditions like giant cell arteritis. The key, of course, is meticulous management of the tapering schedule and vigilant monitoring for side effects.” – Dr. Eleanor Vance, MD, Rheumatology
- “Prescribing Omnacortil is a constant balance of immense benefit versus significant risk. For a severe asthma exacerbation, it can be literally life-saving. However, I always emphasize to my patients the importance of not stopping abruptly and the need to report any new symptoms immediately, especially concerning blood sugar or mood changes.” – Dr. Ben Carter, Pulmonologist
- “After being diagnosed with ulcerative colitis, my first major flare was terrifying. A short course of a higher dose of Omnacortil, followed by a careful taper, brought my symptoms under control within days, allowing me to function again. I’m aware of the side effects, but in that acute scenario, the benefit was undeniable.” – Patient M.K.
- “Long-term low-dose Omnacortil for my rheumatoid arthritis has given me my life back. While I have to be careful about bone health and get regular check-ups, the trade-off for being pain-free and mobile is worth it. My doctor and I have a clear plan, and I feel well-informed and monitored.” – Patient R.S.